Phil Hykin

Moorfields Eye Hospital — United Kingdom

Medicine · Health Sciences

10h-index585citations16works2.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Retinal Diseases and Treatments(15), Retinal Imaging and Analysis(11), Retinal and Optic Conditions(5), Glaucoma and retinal disorders(3), Retinal Development and Disorders(2)

Publications16 total

Sleep and mood in central serous chorioretinopathy
Eye·2025· 2 citedOpen Access
Evolution of fundus autofluorescence patterns over time in patients with chronic central serous chorioretinopathy
Acta Ophthalmologica·2018· 33 citedOpen Access
Retinal morphology and vessel oxygen saturation in normal and diabetic patients
Investigative Ophthalmology & Visual Science·2017Open Access
Predictors of Outcome in Patients with Neovascular Age-Related Macular Degeneration Switched from Ranibizumab to 8-Weekly Aflibercept
Ophthalmology·2016· 26 cited
Perspectives on reticular pseudodrusen in age-related macular degeneration
Survey of Ophthalmology·2016· 88 cited
Caregiver Burden in Patients Receiving Ranibizumab Therapy for Neovascular Age Related Macular Degeneration
PLoS ONE·2015· 73 citedOpen Access
Epidemiology and Aetiopathogenesis of Age-Related Macular Degeneration
2013
Injection frequency and response to bevacizumab monotherapy for diabetic macular oedema (BOLT Report 5)
British Journal of Ophthalmology·2013· 58 cited
Determinants Of Increased Frequency Of Bevacizumab Injections In Patients With Diabetic Macular Oedema (post-hoc Analyses Of Bolt Study)
Investigative Ophthalmology & Visual Science·2012
Exploring Parameters That May Be Associated With The Efficacy Of Response To Intravitreal Bevacizumab (ivB) In A Two-year Prospective Randomised Trial Comparing ivB With Laser Therapy In The Management Of Diabetic Macular Oedema (BOLT Study)
2011· 1 cited
MACULAR PERFUSION DETERMINED BY FUNDUS FLUORESCEIN ANGIOGRAPHY AT THE 4-MONTH TIME POINT IN A PROSPECTIVE RANDOMIZED TRIAL OF INTRAVITREAL BEVACIZUMAB OR LASER THERAPY IN THE MANAGEMENT OF DIABETIC MACULAR EDEMA (BOLT STUDY)
Retina·2010· 68 cited
Novel Mutations and Electrophysiologic Findings in RGS9- and R9AP-Associated Retinal Dysfunction (Bradyopsia)
Ophthalmology·2009· 47 citedOpen Access
POSTERIOR HYALOID CHANGES FOLLOWING INTRAVITREAL TRIAMCINOLONE AND MACULAR LASER FOR DIFFUSE DIABETIC MACULAR EDEMA
Retina·2008· 31 cited
New algorithm for assessing patient suitability for macular translocation surgery
Clinical and Experimental Ophthalmology·2007· 14 cited
The role of photodynamic therapy in ophthalmology.
PubMed·2006· 4 cited
Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles
Experimental Eye Research·2005· 140 cited

Frequent Co-authors

Sobha Sivaprasad(10), Michel Michaelides(5), Luke Nicholson(3), Irini Chatziralli(3), Roxanne Crosby‐Nwaobi(3), Catey Bunce(3), Tünde Pető(3), Zdeněk Gregor(2), Samantha Fraser‐Bell(2), Robin Hamilton(2), Andrew Kaines(2), Sophie Marlowe(2), Iona Alexander(2), Susan M. Downes(2), F. Foster(2), Jignesh Patel(1), Joyce Tombran‐Tink(1), Ian A. Cree(1), Alan C. Bird(1), Rynda Nitiahpapand(1)